Viewing Study NCT00510133


Ignite Creation Date: 2025-12-25 @ 3:08 AM
Ignite Modification Date: 2026-04-07 @ 3:35 AM
Study NCT ID: NCT00510133
Status: COMPLETED
Last Update Posted: 2019-07-09
First Post: 2007-07-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Active Immunotherapy With GRNVAC1 in Patients With Acute Myelogenous Leukemia (AML)
Sponsor: Asterias Biotherapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module